CANF

Can-Fite BioPharma
CANF

Overview Fund Trends Analyst Outlook Journalist POV

11 hedge funds and large institutions have $1.62M invested in Can-Fite BioPharma in 2024 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

0.01% more ownership

Funds ownership: 0.03% → 0.04% (+0.01%)

Holders
11
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$351K
2
+$31K
3
+$27K
4
VF
Virtu Financial
New York
+$27K
5
AWM
Activest Wealth Management
Florida
+$516

Top Sellers

1
-$31.5K
2
-$7.96K
3
-$4.82K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.34M
2
$175K
3
$39.7K
4
$27K
5
$27K
6
$7.74K
7
$1.55K
8
$1.43K
9
$516
10
$477
11
$52
12
–
13
–